Home/Tag: HIV

SLU Researcher Receives $2.3 Million NIH Grant to Expand Youth-Friendly HIV Self-Testing

Nigerian youth are at the epicenter of an expanding HIV crisis in Sub-Saharan Africa. As a country, Nigeria ranks second in the in the world in new HIV-Infections among youth, youth living with HIV and AIDS-related death among a youth population. HIV testing is an important early entry point to accessing preventive education, care and

September 25th, 2018|Categories: Around The State, Disease Specific, HIV|Tags: , , , |

NIH and partners launch HIV vaccine efficacy study

The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. The new Phase 2b proof-of-concept study, called Imbokodo, aims to enroll 2,600 HIV-negative women in sub-Saharan Africa. Of 1.8 million new HIV infections worldwide in 2016,

December 1st, 2017|Categories: Clinical Trials, HIV|Tags: , |

Researchers Discover A New Mechanism of Proteins to Block HIV

Certain IFITM proteins block and inhibit cell-to-cell transmission of HIV Sept. 25, 2015 By Sheena Rice COLUMBIA, Mo. – There is little doubt that the Human Immunodeficiency Virus, or HIV, is devastating. More than 1.2 million people in the United States are living with HIV and more than 47,000 people are diagnosed annually. Now, University of

September 25th, 2015|Categories: Around The State, HIV|Tags: , , |

First Self-injectable HIV Antibody

Tue, 08/11/2015 - 11:45 am Lindsay Hock, Editor Digital illustration of HIV virus in blood stream in color background. Image: RAJ CREATIONZS/ShutterstockHIV has been categorized as “the most intelligent virus in centuries.” This is due to the virus' capability to hide in a reservoir inside organs and, also, because it mutates at a very high

Scientists Unravel Elusive Structure of HIV Protein

June 30, 2015 by Jeff Sossamon COLUMBIA, Mo. – HIV, or human immunodeficiency virus, is the retrovirus that leads to acquired immunodeficiency syndrome or AIDS. Globally, about 35 million people are living with HIV, which constantly adapts and mutates creating challenges for researchers. Now, scientists at the University of Missouri are gaining a clearer idea of what

Stem cell gene therapy developed at UCLA holds promise for eliminating HIV infection

Method modifies immune cells to attack the virus, could be used to treat other diseases Mirabai Vogt-James | June 30, 2015 UCLA Broad Stem Cell Research CenterThe scientists, led by Jerome Zack (left) and Scott Kitchen, found that the technique decreased HIV levels in mice by 80 to 95 percent. Scientists at the UCLA Eli and

Wild chimps teach scientists about gene that encodes HIV-fighting protein

Part of a gene variant present in some wild African chimps is nearly identical to a section of an analogous gene version found in HIV-infected humans who are uncharacteristically slow to progress to full-blown AIDS. MAY 282015 Stanford researchers discovered that some of the chimpanzees in the Gombe Stream National Park, made famous by primatologist

Vault nanoparticles show promise for cancer treatment, potential HIV cure

R&D, by Staff ~ August 22, 2014 A multidisciplinary team of scientists from the Univ. of California, Los Angeles (UCLA) and Stanford Univ. has used a naturally occurring nanoparticle called a vault to create a novel drug delivery system that could lead to advances in the treatment of cancer and HIV. The research team was